Metallothionein Mediates Protection by Fuzi Polymccharide Onneonatalrat Cardiomyocytes with Hypoxia-reoxygenation

LIU Ying,JI Chao,WU Wei-kang
DOI: https://doi.org/10.3969/j.issn.1005-9903.2012.04.047
2012-01-01
Abstract:Objective:The present study was designed to use cultured neonatal rat cardiomyocytes with hypoxia-reoxygenation(H/R) to mimic in vivo ischemia-reperfusion injury(I/R),and investigate the protective mechanism of fuzi polymccharide in cardiomyocytes against hypoxia-reoxygenation injury through metallothionein.Method:Cultured rat myocardial cells were divided into four groups:control,H/R,and fuzi polymccharide treatment groups.The cells in H/R group were incubated primarily in hypoxic buffer solution for 3 hours,thereafter,these cells were incubated for 6 hours in normal culture medium.The cells in fuzi polymccharide treatment group were cultured in medium added with 10.0,1.0,0.1 g·L-1 fuzi polymccharide for 24 hours before H/R.metallothionein of cardiomyocytes was measured by ELIZA,cell apoptosis of cardiomyocytes was measured by flow cytometry,MDA of cardiomyocytes and LDH in cell culture media were also measured.Result:As compared with H/R group,pretreatment with high and moderate dose of fuzi polymccharide increased the synthesis of metallothionein,decreased the synthesis of MDA and release of LDH.High dose of fuzi polymccharide decreased cardiomyocyte apoptosis.Conclusion:These data suggest that fuzi polymccharide pretreatment can protect cardiomyocytes from H/R injury.The mechanism is related to its enhancement of metallothionein synthesis,scavenging of oxygen free radical,and thus protection against apoptosis.
What problem does this paper attempt to address?